These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effect of the expression of DR alpha E beta NOD molecule on the development of insulitis and diabetes in the non-obese diabetic (NOD) mouse. Yamane K; Yamamoto K; Yoshikawa Y; Sasazuki T Clin Exp Immunol; 1996 Jan; 103(1):141-8. PubMed ID: 8565273 [TBL] [Abstract][Full Text] [Related]
4. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nishimoto H; Kikutani H; Yamamura K; Kishimoto T Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721 [TBL] [Abstract][Full Text] [Related]
6. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse. La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117 [TBL] [Abstract][Full Text] [Related]
7. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Sumida T; Furukawa M; Sakamoto A; Namekawa T; Maeda T; Zijlstra M; Iwamoto I; Koike T; Yoshida S; Tomioka H Int Immunol; 1994 Sep; 6(9):1445-9. PubMed ID: 7819154 [TBL] [Abstract][Full Text] [Related]
8. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain. Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026 [TBL] [Abstract][Full Text] [Related]
9. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes. Reich EP; Sherwin RS; Kanagawa O; Janeway CA Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922 [TBL] [Abstract][Full Text] [Related]
10. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes. Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065 [TBL] [Abstract][Full Text] [Related]
12. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066 [TBL] [Abstract][Full Text] [Related]
13. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes. Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280 [TBL] [Abstract][Full Text] [Related]
14. Development of autoimmune insulitis is prevented in E alpha d but not in A beta k NOD transgenic mice. Uehira M; Uno M; Kürner T; Kikutani H; Mori K; Inomoto T; Uede T; Miyazaki J; Nishimoto H; Kishimoto T Int Immunol; 1989; 1(2):209-13. PubMed ID: 2562156 [TBL] [Abstract][Full Text] [Related]
15. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Miyazaki T; Uno M; Uehira M; Kikutani H; Kishimoto T; Kimoto M; Nishimoto H; Miyazaki J; Yamamura K Nature; 1990 Jun; 345(6277):722-4. PubMed ID: 2113614 [TBL] [Abstract][Full Text] [Related]
16. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line. Chosich N; Harrison LC Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738 [TBL] [Abstract][Full Text] [Related]
17. No evidence for TCR V beta repertoire changes influencing disease protection in E-transgenic NOD mice. Spetz AL; Brenden N; Pilström B; Böhme J Scand J Immunol; 1995 Jul; 42(1):135-9. PubMed ID: 7631135 [TBL] [Abstract][Full Text] [Related]
18. Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen-presenting cells. Pilström B; Böhme J Immunology; 1997 Apr; 90(4):483-8. PubMed ID: 9176099 [TBL] [Abstract][Full Text] [Related]
19. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules. Rajagopalan G; Kudva YC; Flavell RA; David CS Diabetes; 2003 Feb; 52(2):342-7. PubMed ID: 12540606 [TBL] [Abstract][Full Text] [Related]
20. Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules. Miyazaki T; Matsuda Y; Toyonaga T; Miyazaki J; Yazaki Y; Yamamura K Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9519-23. PubMed ID: 1409662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]